35th Annual Scientific Congress of Malaysian Oncological Society

11th-13th October 2024  |  Setia SPICE Convention Centre, Penang
11-13 Oct 2024
Setia SPICE Convention Centre, Penang
If you are using mobile devices, please swipe to the right to view the full content

THURSDAY, 10 OCTOBER 2024

The pre-congress is by invitation only.

TIME PRE-CONGRESS WORKSHOP
08:45-09:00 Registration & Tea  
09:00-09:15 Welcome and introduction Marniza Bt Saad / Soo Hoo Hwoei Fen
09:15-09:30 Lecture 1: Teaching Clinical Reasoning in a Busy Practice Marniza Bt Saad
09:30-09:45 Lecture 2: Assessment, evaluation & appraisal Fong Chin Heng
09:45-10:30 Skill activity 1: WBA: Conducting & appraising CBD (with trainees) Fong Chin Heng + All facilitator
10:30-10:45 Lecture 3: Reflective practice Marfuah Nik Eezamuddeen 
10:45-11:30 Skill activity 2: Reflective Practice in ‘Postgraduate training’ (with trainees) Marfuah Nik Eezamuddeen + All facilitator
11:30-11:45 Break  
11:45-12:00 Lecture 4: The Effective Supervisor Rachel Cooper
12:00-12:15 Lecture 5: How to Give Productive Feedback that Leads to Positive Changes? Tom Rogue
12:15-13:00 Skill Activity 3: Giving Productive Feedback Tom Roogue & Rachel Cooper
12:45-13:30 Lunch  
13:30-13:45 Lecture 6: Managing poor performance Soo Hoo Hwoei Fen
13:45 – 14:15 Skill Activity 4: Managing poor performance-Different case scenarios Soo Hoo Hwoei Fen + All facilitator
14.15-15:00 Skill Activity 5: Awaiting HITAP feedback Chittawan Poonsiri
15:00-15:15 Break Break
15:15-15:30 Lecture 7: Coaching trainee in era with abundance of online resources Melvin Chua Lee Kiang
15.30-16.00 Photo taking, Tea & Closing All

FRIDAY, 11 OCTOBER 2024

TIME BALLROOM 1 BALLROOM 2 BALLROOM 3
0800-0930 REGISTRATION
0930-1100 Grand Forum: Bridging the Gaps
Chairperson: Mohamed Ibrahim Bin Dato' Hj. Abdul Wahid & Tan Hui Ling 
0930-0950 The Ideal: The Comprehensive Oncological Care Of The Future - Taking A Wider View On Improving Future Cancer Outcomes - Radiotherapy Access
Yeoh Kheng Wei
0950-1005 The Challenge: Escalating cost of cancer treatment: what do we expect in the future? (radiotherapy access)
Dr Sharliza Mohd Salleh
1005-1020 Singapore: Learning The Experience Of The "Cancer Drug Reimbursement System" In Singapore
Ravindran Kanesvaran, Singapore
1020-1030 Thailand: Delivering Excellance Cancer Care: Challenges And Opportunities From Thailand Perspective
Chittawan Poonsiri, Thailand
1030-1040 Malaysia: Where Do We Stand In Malaysia, In Term Of Drug Affordability And National Cancer Drug Reimbursement System?
Mastura Md Yusof
1040-1100 Forum Discussion
1100-1130 Opening Ceremony - Opening of ASCOMOS Penang 2024
1130-1230 KEYNOTE ADDRESS: ONCOLOGY TRAINING - What Do We Need For The Future?
Chairperson: Lee Cheen Leng

Speaker:
Rachel Cooper, United Kingdom
Marniza Bt Saad
Soo Hoo Hwoei Fen
1230-1300 Repartitioning of halls
1300-1400

LUNCH SYMPOSIUM BY BMS
LUNCH SYMPOSIUM 2 LUNCH SYMPOSIUM 3
1400-1530 Early Lung Cancer
Chairpersons:
Early Breast Cancer
Chairpersons: Doris Chow Sze Ying
Hepatobiliary
Chairpersons: Rosmawati Binti Mohamed
1400-1420 Lung Cancer Screening & Smoking Cessation
Liam Chong Kin
Anthracyclines - Is It Still Relevant In Early Breast Cancer?
Samuel Ow, Singapore
Combination Therapy In Intermediate HCC: Where We Stand?
Stephen Chan, Hong Kong
1420-1440 Debate: Neoadjuvant Chemo-Immunotherapy Before Surgery Should Be The SOC ForSstage IB (>4cm) - IIIA NSCLC
Proponent: Cheah Soon Keat
Opponent: TBC
Adjuvant Endocrine Therapy In Premenopausal Women - Beyond Tamoxifen
Kiley Loh
Indications Of SBRT In Hepatobiliary Cancer, Clinical Aspects Of Radiotherapy Planning
Maria Hawkins, United Kingdom
1440-1500 How Do I Treat Stage III NCLSL
Prof Michael Chao, Australia
Role Of Rt/Axillary Treatment In The Era Of Neoadjuvant Therapy
Mastura Md Yusof
MDT Case Discussion
Lim Yueh Ni
Loh Kok Beng
Jasjit Singh Nijhar
1500-1530 (10 minutes Q&A) Q&A Q&A
1530-1610

TEA SYMPOSIUM BY JOHNSON & JOHNSON

From Progression to Possibilities: Shaping Tomorrow's Management in EGFRm NSCLC

The Art of Medicine in Lung Cancer
  • Latest Updates in EGFRm NSCLC
  • What Happens After Progression?
Speaker: James Yang, Taiwan

TEA SYMPOSIUM BY MERCK

TEA SYMPOSIUM BY ASTRAZENECA
1610-1700 Advanced Lung Cancer
Chairpersons: Amir Shah
Advanced Breast Cancer
Chairpersons: Kiley Loh
Cancer genomics
Chairpersons:
1610-1630 Management Of Oligometastatic Disease In Lung Cancer
James Yang, Taiwan
Weighing The Cost And Benefits Of Novel Therapies In Metastatic Breast Cancer
Ho Gwo Fang
Genetic Testing in Clinic: A Practical Guide
Yoon Sook Yee
1630-1650 Post-Progression Management For Advanced Nslcl With Driver Mutation Treated With TKI
MDT Case Discussion
Samuel Ow, Singapore
Teoh Mei Shi
Ivy Ho
Riding the Genomic Wave: Medical Genetics and Therapy
Winnie Ong
1650-1700 Q&A Q&A Q&A
1900-2200 CONGRESS DINNER (R.S.V.P ONLY)

SATURDAY, 12 OCTOBER 2024

TIME BALLROOM 1 BALLROOM 2 BALLROOM 3
0830-0900 REGISTRATION
0900-0945 SCIENTIFIC PLENARY (IV) RESEARCH - Overcoming challenges in oncological clinical trials (phase 1-3) in Malaysia

Chairperson:
Speaker: Dr Voon Pei Jye
0945-1000 Repartitioning of halls
1000-1045

TEA SYMPOSIUM BY ZUELLIG PHARMA
EBC / Abema

TEA SYMPOSIUM BY PFIZER
Unveiling the Future: Redefining ALKare into Chronic Disease

TEA SYMPOSIUM BY SERVIER
1045 - 1155 Gynecologic Oncology
Chairpersons: Ang Soo Fan
Lower GI
Chairpersons:
Head & Neck
Chairpersons: Ho Kean Fatt
1045-1105 New Standard Of Care For Locally Advanced And Metastatic Cervical Cancer
Jennifer Leong
Neoadjuvant Strategies For Locally Advanced Rectal Cancer - TNT, How To Implement This In Malaysia
Patricia Shamani Soosainathan
Reinventing The Wheel For Radiotherapy In Nasopharyngeal Carcinoma
Melvin Chua, Singapore
1105-1125 Endometrial Cancer – Landmark Trials & Biomarker Directed Therapies
John Chia Whay Kuang, Singapore 
Update: Management Of Peritoneal Metastasis: Hipec Is Not Hot Air!
James Khaw Chern Wern
Transoral Robotic Surgery - Malaysian Experience
Mohd Razif Mohamad Yunus
Ahmad Kusyairi Khalid
1125-1145 MDT Cases Discussion:
Stage I Ovarian, Recurrence Ovarian on PARP-i, Locally Advanced Cervical, Carcinosarcoma of Uterus; Metastatic Endometrial Cancer, etc


Presenter: Ang Soo Fan
Panel:
Jennifer Leong
John Chia Whay Kuang
Chew Ghee Kheng
Updates Systemic Therapy For Metastatic Colorectal Cancer
Nur Fadhilina Abdul Satar
Metastatic Head And Neck Carcinoma - Changing Treatment Paradigm
Wan Zamaniah Bt Wan Ishak
1145-1155 Q&A Q&A Q&A
1155-1305 Nursing
Chairpersons:
Prostate
Chairpersons:
Nuclear Medicine
Chairpersons:
1155-1215 Optimal Care Of Vascular Implanted Devices
Punitha A/P Arumohan
Hypofractionated Or Ultrahypofractionated Prostate Radiotherapy?
Thiraviyam Elumalai, United Kingdom
Diagnostic Nuclear Medicine For Solid Tumours In Malaysia
Au Mun Yee
1215-1235 Optimal Management Of Fungating Breast Wound
Norhashimah Bt Khadir
Dosimetric Advantages Of Spacers In Prostate Radiotherapy
Michael Chao, Australia
Therapeutic Nuclear Medicine For Solid Tumours In Malaysia
Alex Khoo Chee Hoe
1255-1305 Q&A Q&A Q&A
1305 - 1405

LUNCH SYMPOSIUM BY ROCHE

LUNCH SYMPOSIUM BY MSD
Metastatic Gastric Ca

LUNCH SYMPOSIUM BY ASTRAZENECA
1405-1510 CNS
Chairpersons:
Bladder
Chairpersons: Shazril Imran
Physics/Radiation therapist
Chairpersons:
1405-1425 Tumour Treating Fields (TTF) For The Management Of Glioma - The Asian Experience
Daniel Chan, Singapore
Cost Effective Treatment For Muscle Invasive Bladder Cancer For Developing Countries
Nuradh Joseph, Sri Lanka
SBRT Liver Motion Management Practice in Malaysia (Radiation Therapist Perspective)
Mohd Khairul b. Mohd Zambri
1425-1445 Is There A Role For Targeted Therapy In Gliomas?
Sith Sathornsumetee, Thailand
Is Radiosensiting Radical Radiotherapy in Bladder, Superior Than Surgery?
Thiraviyam Elumalai,  United Kingdom
Overcoming Challenges in SBRT for The Spine
Zulaikha Jamalludin
1445-1505 Management Of G2/3 Glioma Or Case Discussion
Sith Sathornsumetee, Thailand
Optimal Management Of Metastatic Urothelial Carcinoma
Ravindran Kanesvaran, Sinagpore
SBRT for Challenging Sites: Intrahepatic, Renal, and Pericardial Lesions
Robin Hill, Australia
1505-1510 Q&A Q&A Q&A
1510-1555

TEA SYMPOSIUM BY NOVARTIS

TEA SYMPOSIUM BY IPSEN

TEA SYMPOSIUM BY AMGEN
1555-1645 Research
Chairpersons:
Kidney
Chairpersons:
Immunotherapy
Chairpersons:
1555-1615 Implementing Radiotherapy Related Research in a Developing Country
Nuradh Joseph, Sri Lanka
Adjuvant Therapy in Renal Cell Carcinoma : Where Do We Now Stand?
Adlinda Bt Alip
Updates in Predictive Markers for Immunotherapy and Treatment of Solid Tumours
Lee Fong Wan
1615-1635 Delivering Support for a Successful Investigator Initiated Research in Oncology
Yoon Chee Kin
Systemic Therapy Metastatic Renal Cell, Sequencing Optimal Therapy
Lee Cheen Leng
Recognising Rare and Lethal Immunotherapy Related Adverse Events and Management
Nellie Cheah Lay Chin
1635-1645 Q&A Q&A Q&A
1700-1900 ANNUAL GENERAL MEETING (MOS MEMBERS ONLY)

SUNDAY, 13 OCTOBER 2024

TIME BALLROOM 1 BALLROOM 2 BALLROOM 3
0830-0900 REGISTRATION
0900-0945 SCIENTIFIC PLENARY (III) ARTIFICIAL INTELLIGENCE: Improving cancer diagnostics and therapeutics using artificial Intelligence - current state of affair and future potentials.

Speaker: Prof Junya Fukuoka, Japan
0945-1000 Repartitioning of halls
1000-1045

TEA SYMPOSIUM BY GENESOLUTION

Minimal Residual Disease Monitoring
Comprehensive Genomics Profiling for Target Therapy Selection

TEA SYMPOSIUM BY EISAI-MSD : met RCC
TEA SYMPOSIUM 3-3
1045-1200 Upper GI
Chairpersons: Nellie Cheah Lay Chin & Lim Shyang Yee
Sarcoma
Chairpersons: Ho Kean Fatt
Palliative Care
Chairpersons: Doris Chow Sze Ying
1045-1105 Oligomets in Upper GI Cancer - Any Role of Surgery?
Lim Shyang Yee
Giant Cell Tumours - An Update
Prashant Narhari
National Pain Management CPG (2nd Edition)
Aaron Hiew Wi Han
1105-1125 Peri-Operative Treatment In Upper Gi Cancer
Eng Jie Yi
Managing "Whoops!" Surgery
Tan Ai Lian
Prashant Narhari
Dying Well - Myth or Possibility
Oo Loo Chan 
1125-1145 Radiotherapy For Ugi Ca - Current Status And Future Direction
Maria Hawkins, United Kingdom
GIST Updates
Wong Yoke Fui
Advanced Care Plan - What Is It?
Lim Liang Yik
1145-1200 Q&A Q&A Q&A
1200-1315 Thyroid
Chairpersons: Yap Beng Khiong
Free Paper Oral Presentations
Chairpersons: Eunice Ong
Patient Advocacy
Chairpersons:
1200-1220 Sequencing Therapies for Metastatic Thyroid Carcinoma Prospective Studies
Navigating Public Healthcare With a Diagnosis Of Cancer
Sazrah Bt Shuib
1220-1240 Management of Low Risk Thyroid Carcinoma
Alex Khoo Chee Hoe
Retrospective Studies
Where To Find Support After Diagnosis Of Cancer?
Jimmy Kijon
1240-1300 Anaplastic/Poorly Differentiated Thyroid Carcinoma - What Are Our Options
Choong Swee Hsia
Case Series/Case Studies
Surviving Cancer - How To Carry On?
Loo Chia Ming
1300-1315 Q&A Judging session Q&A
1315-1345 CLOSING CEREMONY

DISCLAIMER: Whilst every attempt would be made to ensure all aspects of the conference mentioned in the Programme will take place as scheduled, the Organising Committee assumes no responsibility should it fail to materialize due to any unforeseen circumstances.

VIEW PROGRAMME IN PDF